IFPMA Flagship Event @WHA71 - 23 of May, 6pm
On the occasion of its 50th anniversary, IFPMA invites you to join an event where mutiple stakeholders will be coming together to discuss the enablers of health progress over the past fifty years, and what is needed to ensure continued progress going forward.
Details and RSVP
Global Code Comparison
An overview of the global R&D-based biopharmaceutical industry’s self-regulation mechanisms and the commitment of IFPMA members to ethical promotion and interactions for the safety and benefit of patients worldwide.
Read More
AMR Industry Alliance
Together with 100+ companies and trade associations from the AMR Industry Alliance, IFPMA is committed to stop superbugs. Check out our first Progress Report!
Read More
NEW COMPREHENSIVE ONLINE PLATFORM:
What are falsified medicines? What is their impact? How to tackle this global challenge?
Read More
HealthyHorizons Campaign - The Road to Universal Health Coverage
Along with our partners, we are exploring the path to Universal Health Coverage. Join the Devex campaign “HealthyHorizons: The Road to Universal Health Coverage”.
Read More
IFPMA Corporate Brochure - Committed to a Healthier Future
We hope you find this brochure informative to gain better understanding of the contributions of our industry. We are passionate about the role we play in finding effective and sustainable solutions to today’s most pressing health concerns and look forward to continuing the dialogue with our partners
Read More
IFPMA HEALTH PARTNERSHIPS DIRECTORY
IFPMA hosts the Health Partnerships Directory, a continuously expanding online database that allows users to view, in depth, health partnerships from across the world that involve the research-based biopharmaceutical industry.
Read MoreIFPMA in Brief
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Tackling Global health challenges
The research-based biopharmaceutical industry is proud to be playing its part in the quest to find effective and sustainable solutions to today’s most pressing health concerns.
Read More
Boosting Innovation and Access
The research-based biopharmaceutical industry is thinking creatively about its innovation and business models to meet new challenges, and is working in collaboration with different players from the scientific community.
Read More
Strengthening Regulatory Systems
Patients everywhere should be treated with high quality medicines and vaccines. Science-based guidelines provide direction for the development, manufacture, and supply of medicines.
Read More
Building trust
The healthcare community and the public must be confident that research-based biopharmaceutical industry and their employees, wherever they operate, communicate and act in an ethical and professional manner.
Read More
Discovering medicines and Vaccines
Never have people lived longer and never have so many children been saved from dying in the first years of life. Medicines and vaccines extend and improve the quality of life for many people.
Read More
Our Resources
The Globalisation of the Pharmaceutical Industry
Read More
IFPMA & IFPW Supply chain session 2016 Global Health Forum - long version
The session that took place at 2016 GHF ‘Shaping a sound supply chain ecosystem’ gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip’s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the essential...
Read More
The African Global Health Leaders Fellowship launched to support the future of health in Africa
The African Global Health Leaders Fellowship launched to support the future of health in Africa Geneva, 24 January 2018│ The Centre on Global Health Security at Chatham House, the Global Health Centre at the Graduate Institute and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced yesterday the establishment...
Read More
IFPMA @DIAEurope
Read More
ABPI, EFPIA, and IFPMA issue joint statement on AMR
ABPI, EFPIA and IFPMA issue joint statement following publication of the final report by the Review on AMR The Association of the British Pharmaceutical Industry (ABPI), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) have today issued a joint...
Read More
Join IFPMA
There are many challenges in improving public health policy for current and future generations. To play an effective role in advancing these policies, the research-based biopharmaceutical industry needs an informed and credible voice in the conversation with the global health community. That voice is IFPMA.
LEARN MOREOur Blog
What a difference 70 years can make in global health
This blog was first published on Diplomatic Courier on 11 April 2018. 1948 saw the birth of the UK’s National Health Service providing healthcare free for all at the point of delivery - and 55 countries meet for the inaugural World Health Assembly. Seven decades later, Ebola and Zika outbreaks, old diseases reappearing in conflict zones, polio that is still resisting eradication, chronic “life-style”...
Read More
Accelerating the development and delivery of new innovations for a TB-free world
Before the World Economic Forum, Davos’ first claim to fame was as a haven for wealthy tuberculosis sufferers in the 1800s and 1900s: the rarefied air of the Magic Mountain, as Thomas Mann dubbed it, offered a “certain” cure. The Davos visitors of those days, like Mann’s Hans Castorp, were a small minority of TB sufferers. Today, as then, TB is a disease linked to...
Read More
How smart boxes are helping vaccine makers deliver more
Here we speak with Michaël Attlan, Head of the New Technologies (NT) Platform at Sanofi Pasteur, about how technology is transforming vaccine delivery. Prior to heading the NT Platform, Michaël led Sanofi Pasteur’s Traveler & Endemic Vaccine Franchise. His work in yellow fever, cholera, rabies, and Japanese encephalitis reflects his and Sanofi Pasteur’s commitment to public health around the world. Vaccine demand has risen steadily for...
Read MoreLatest Tweets
@IFPMA @IFPMA 
@IFPMA @IFPMA @IFPMA 